Our in vivo evidence, for the first time demonstrates the neuro-protective role of PGC-1α in an ALS mouse model, suggesting that PGC-1α might be a potential therapeutic target for early intervention in ALS. This evidence concerns the gene PPARGC1A and amyotrophic lateral sclerosis.